Veterinary Sciences articles for United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 66

Article ‘Count’ for Veterinary Sciences.

Journal Count Share
2 1.82
Evolution of antibody cross-reactivity to influenza H5N1 neuraminidase from an N2-specific germline 0.82
Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations 1.00
1 1.00
Identification of and Response to Influenza A(H5) in Off-the-Shelf Raw Milk—Santa Clara County, California, November–December 2024 1.00
2 1.32
Alternative Vertebrate and Invertebrate Model Organisms Show Similar Sensitivity as Rodents to a Diverse Set of Chemicals 0.32
Detection of Hemagglutinin H5 Influenza A Virus RNA and Model of Potential Inputs in an Urban California Sewershed 1.00
1 1.00
Immunopathogenesis of lethal H5N1 avian influenza virus clade 2.3.4.4b infection in macaques 1.00
1 0.90
Effect of pH on small-molecule inhibitor binding to influenza virus hemagglutinin 0.90
2 2.00
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site 1.00
Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling 1.00
1 0.72
Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza 0.72
2 2.00
Development and Characterization of Candidate Vaccine Viruses against High Pathogenicity Avian Influenza A(H5) Viruses for Rapid Pandemic Response 1.00
Machine learning-enabled quantification of hepatocellular necrosis in the liver after lethal Marburg and Ebola virus exposures 1.00
1 1.00
Ecology and spread of the North American H5N1 epizootic 1.00
24 17.98
Dairy cows infected with influenza A(H5N1) reveals low infectious dose and transmission barriers 1.00
Mapping the canine gut microbiome: insights from the Dog Aging Project 0.87
Disentangling the drivers and host-mediated global spread of H7 influenza A virus 0.06
Genomic analysis of high pathogenicity avian influenza viruses from Antarctica reveals multiple introductions from South America 0.04
Increased contact transmission of contemporary Human H5N1 compared to Bovine and Mountain Lion H5N1 in a hamster model 1.00
Mapping global avian influenza risk patterns through waterbird activity entropy 0.14
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses 0.44
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice 0.92
MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses 1.00
Advancing A(H5N1) influenza risk assessment in ferrets through comparative evaluation of airborne virus shedding patterns 1.00
IFITM3 deficiency drives SARS-CoV-2 adaptation while preserving variant-specific traits 1.00
Multi-generational koala pedigree analysis reveals rapid changes in heritable provirus load associated with life history traits 0.40
SARS-CoV-2 within-host population expansion, diversification and adaptation in zoo tigers, lions and hyenas 0.95
Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin 0.95
Host switching mutations in H5N1 influenza hemagglutinin suppress site-specific activation dynamics 1.00
Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity 0.60
Design and nonviral delivery of live attenuated vaccine to prevent chronic hepatitis C virus-like infection 0.86
Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3 0.88
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies 0.86
Genotype B3.13 influenza A(H5N1) viruses isolated from dairy cattle demonstrate high virulence in laboratory models, but retain avian virus-like properties 0.97
Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin–Matrix-M nanoparticle vaccine induces neutralizing responses in nonhuman primates 1.00
The impact of highly pathogenic avian influenza H5N1 virus infection on dairy cows 1.00
Highly pathogenic avian influenza H5N1 clade 2.3.4.4b genotype B3.13 is highly virulent for mice, rapidly causing acute pulmonary and neurologic disease 1.00
Efficacy of baloxavir marboxil against bovine H5N1 virus in mice 0.05
3 2.76
Rapid expansion of genotype D1.1 A(H5N1) influenza viruses in wild birds across North America during the 2024 migratory season 0.76
H5N1 influenza virus stability and transmission risk in raw milk and cheese 1.00
Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025 1.00
2 1.96
Surveillance on California dairy farms reveals multiple possible sources of H5N1 influenza virus transmission 0.96
Mammalian antiviral proteins ZAP and KHNYN can independently restrict CpG-enriched avian viruses 1.00
3 2.24
An intronic variant in Ferredoxin Reductase (FDXR) creates a cryptic exon in Quarter Horses with Equine Juvenile Spinocerebellar Ataxia 1.00
Two genes, one culprit - a functional candidate validation of a SPATA7 deletion in dogs with day blindness/retinal degeneration 0.89
Charting the equine miRNA landscape: An integrated pipeline and browser for annotating, quantifying, and visualizing expression 0.34
8 4.80
Efficient replication of influenza D virus in the human airway underscores zoonotic potential 1.00
Distinct evolutionary patterns of endemic and emerging parvoviruses and the origin of a new pandemic virus 0.90
Small molecule–constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins 0.27
A canine PLP1 missense variant differentiates oligodendrocyte maturation in connatal and classical Pelizaeus–Merzbacher disease 0.15
Structural basis for a potent human neutralizing antibody targeting a conserved epitope on the H7 hemagglutinin head 0.07
Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections 1.00
Landscape changes elevate the risk of avian influenza virus diversification and emergence in the East Asian–Australasian Flyway 0.50
Mechanistic insights into the small-molecule inhibition of influenza A virus entry 0.91
3 0.18
Polymerase trapping as the mechanism of H5 highly pathogenic avian influenza virus genesis 0.08
The oncogenome of the domestic cat 0.02
Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals 0.08
5 4.07
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models 1.00
Blood feeding triggers the terminal differentiation of precursor cells in tick salivary glands 0.98
PB2 and NP of North American H5N1 virus drive immune cell replication and systemic infections 0.10
Repeated oral exposure to H5N1 influenza virus in pasteurized milk does not cause adverse responses to subsequent influenza infection 1.00
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations 1.00
5 4.88
Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice 0.92
Baloxavir alleviates severe disease and viremia in ferrets infected with avian- or bovine-origin influenza A(H5N1) virus 0.96
An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques 1.00
A replicating RNA vaccine protects cynomolgus macaques against lethal clade 2.3.4.4b influenza A H5N1 virus challenge 1.00
Preexisting immunity to the 2009 pandemic H1N1 virus reduces susceptibility to H5N1 infection and disease in ferrets 1.00

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.